GLENVIEW CAPITAL MANAGEMENT, LLC is an institutional investment manager that files quarterly 13F reports with the SEC. As of Q2 2026, the fund manages $5.5B in reported equity holdings across 44 positions. The largest holdings are GPN (11.8%), CVS (9.1%), THC (7.6%), TMO (5.7%), AMZN (5.5%). The portfolio is concentrated in Other (80.1%), Healthcare (11.7%), Communication Services (5.3%). Data sourced from SEC EDGAR 13F filings (CIK 1138995).